| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6822883 | Schizophrenia Research | 2016 | 8 Pages |
Abstract
Our findings suggest that patients taking the LAI risperidone may be more effective in some but not all outcome measures; however, risperidone was also associated with higher medical costs in the Taiwanese healthcare setting.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Chi-Shin Wu, I-Chih Cheng, Jung Feng, Chun-Lin Chen,